Compare Automatic Data Processing Inc (ADP) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Automatic Data Processing Inc vs BridgeBio Pharma Inc — how do they compare? Automatic Data Processing Inc trades at $270.3 (market cap $107.69B), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B). The key difference: Automatic Data Processing Inc is far larger — about 6.6× BridgeBio Pharma Inc's market cap, and Automatic Data Processing Inc pays a 2.51% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| ADP | BBIO | |
|---|---|---|
Market Cap | $107.69B | $16.36B |
Sector | Industrials | Health |
52-Week High | $309.03 | $90.17 |
52-Week Low | $188.79 | $47.29 |
Enterprise Value | $108.73B | $18.14B |
Dividend Yield | 2.51% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Automatic Data Processing Inc
ADP is a provider of payroll and human capital management solutions servicing the full scope of businesses from micro to global enterprises. ADP was established in 1949 and serves over 990,000 clients primarily in the United States. ADP's employer services segment offers payroll, HCM solutions, HR outsourcing, insurance and retirement services. The smaller but faster-growing PEO segment provides HR outsourcing solutions to small and midsize businesses through a co-employment model.
Read more on ADP →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
